Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference Formulation.
Clinical trial NCT00381251 · COMPLETED
Trial details
- NCT number
- NCT00381251
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.